Prognostic factor studies in oncology: osteosarcoma as a clinical example
- PMID: 11173148
- DOI: 10.1016/s0360-3016(00)01507-8
Prognostic factor studies in oncology: osteosarcoma as a clinical example
Abstract
Objective: Prognostic factor studies are abundant in oncology. Nevertheless, most of them have very limited impact on clinical practice, in part because many of them have a low statistical power. The importance of statistical power is illustrated using bootstrap resampling of data from a series of osteosarcoma patients.
Methods and materials: Osteosarcoma is a rare disease, the incidence being just a few cases per million person-years in the Western World. Very few Phase III studies have been conducted in the disease, and much knowledge on therapeutic progress has come from Phase II studies. This has caused controversy concerning the validity of historical controls, which again has stimulated interest in the identification of prognostic factors in this disease. A literature search in the National Library of Medicine MEDLINE database was performed to identify prognostic factor studies in osteosarcoma published between 1975 and 1998. Monte Carlo methods, so-called bootstrap resampling, are used to investigate the importance of sample size based on survival data for a previously published series of 158 osteosarcomas treated with surgery alone.
Results: Most published studies are too small to provide useful information on prognostic factors in osteosarcoma. Three-quarters of the papers reviewed included less than 100 patients with osteosarcoma. More than 20 different potential prognostic factors were included in these papers. Inherent differences between studies and poor reporting hamper a synthesis of information from various studies. The results from the bootstrap resampling illustrate how the majority of published studies would miss even quite significant prognostic factors.
Conclusions: An effort is needed to improve the design, conduct, and reporting of prognostic studies in oncology.
Similar articles
-
Prognostic factors in osteosarcoma: a critical review.J Clin Oncol. 1994 Feb;12(2):423-31. doi: 10.1200/JCO.1994.12.2.423. J Clin Oncol. 1994. PMID: 8113851 Review.
-
Survival rate and prognostic factors of conventional osteosarcoma in Northern Thailand: A series from Chiang Mai University Hospital.Cancer Epidemiol. 2015 Dec;39(6):956-63. doi: 10.1016/j.canep.2015.10.016. Epub 2015 Nov 9. Cancer Epidemiol. 2015. PMID: 26540607
-
Metastatic osteosarcoma at diagnosis: prognostic factors and long-term outcome--the French pediatric experience.Cancer. 2005 Sep 1;104(5):1100-9. doi: 10.1002/cncr.21263. Cancer. 2005. PMID: 16015627
-
Survival and prognostic factors at time of diagnosis in high-grade appendicular osteosarcoma: a 21 year single institution evaluation from east Denmark.Acta Oncol. 2018 Mar;57(3):420-425. doi: 10.1080/0284186X.2017.1351620. Epub 2017 Jul 25. Acta Oncol. 2018. PMID: 28741397
-
Effect of timing of pulmonary metastasis occurrence on the outcome of metastasectomy in osteosarcoma patients.J Pediatr Surg. 2019 Apr;54(4):775-779. doi: 10.1016/j.jpedsurg.2018.06.019. Epub 2018 Jun 23. J Pediatr Surg. 2019. PMID: 30005831 Review.
Cited by
-
Letter to the Editor concerning "Surgical treatment of sacral chordoma: survival and prognostic factors" by C. Ruosi et al. (Eur Spine J; 2015; 24(Suppl 7):S912-S917.Eur Spine J. 2017 Jan;26(1):281-282. doi: 10.1007/s00586-016-4819-3. Epub 2016 Oct 18. Eur Spine J. 2017. PMID: 27757683 No abstract available.
-
Reporting Recommendations for Tumor Marker Prognostic Studies (REMARK): explanation and elaboration.PLoS Med. 2012;9(5):e1001216. doi: 10.1371/journal.pmed.1001216. Epub 2012 May 29. PLoS Med. 2012. PMID: 22675273 Free PMC article.
-
Relationships between levels of CXCR4 and VEGF and blood-borne metastasis and survival in patients with osteosarcoma.Med Oncol. 2011 Jun;28(2):649-53. doi: 10.1007/s12032-010-9493-4. Epub 2010 Mar 27. Med Oncol. 2011. PMID: 20349215
-
Outcomes of comprehensive treatment for primary osteosarcoma.SAGE Open Med. 2020 May 20;8:2050312120923177. doi: 10.1177/2050312120923177. eCollection 2020. SAGE Open Med. 2020. PMID: 32547749 Free PMC article.
-
Reporting of prognostic studies of tumour markers: a review of published articles in relation to REMARK guidelines.Br J Cancer. 2010 Jan 5;102(1):173-80. doi: 10.1038/sj.bjc.6605462. Epub 2009 Dec 8. Br J Cancer. 2010. PMID: 19997101 Free PMC article. Review.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical